These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4145680)

  • 1. Chemotherapy in Hong Kong.
    Horsfall PA
    Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():52. PubMed ID: 4145680
    [No Abstract]   [Full Text] [Related]  

  • 2. A study in Hong Kong to evaluate the role of pretreatment susceptibility tests in the selection of regimens of chemotherapy for pulmonary tuberculosis--second report. A Hong Kong Tuberculosis Treatment Services/British Medical Research Council Investigation.
    Tubercle; 1974 Sep; 55(3):169-92. PubMed ID: 4220080
    [No Abstract]   [Full Text] [Related]  

  • 3. A study in Hong Kong to evaluate the role of pretreatment susceptibility tests in the selection of regiments of chemotherapy for pulmonary tuberculosis. Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation.
    Am Rev Respir Dis; 1972 Jul; 106(1):1-22. PubMed ID: 4624794
    [No Abstract]   [Full Text] [Related]  

  • 4. [Controlled trial of 6 to 8 month chemotherapeutic regimens in the treatment of pulmonary tuberculosis. A study of Hong Kong Chest Service/British Medical Research Council/].
    Aquinas M
    Bull Int Union Tuberc; 1978 Dec; 53(4):253. PubMed ID: 387136
    [No Abstract]   [Full Text] [Related]  

  • 5. Singapore tuberculosis treatment survey.
    Chan W
    Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():44-8. PubMed ID: 4145678
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary results of the Hong Kong/British Medical Research Council second controlled trial of short-course antituberculosis regimens [proceedings].
    Pang SC
    Tubercle; 1978 Mar; 59(1):64. PubMed ID: 345573
    [No Abstract]   [Full Text] [Related]  

  • 7. A service program of antituberculosis chemotherapy with five drugs for four months in the treatment of drug addicts and prisoners with pulmonary tuberculosis in Hong Kong. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1980 Sep; 122(3):417-24. PubMed ID: 7416617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council Investigation.
    Tubercle; 1974 Mar; 55(1):1-27. PubMed ID: 4620294
    [No Abstract]   [Full Text] [Related]  

  • 9. Antituberculous therapy and acute liver function.
    Ong EL
    Lancet; 1995 May; 345(8958):1171. PubMed ID: 7723557
    [No Abstract]   [Full Text] [Related]  

  • 10. Standard chemotherapy and its application in the tuberculosis programme.
    Pamra SP
    Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():31-5. PubMed ID: 4145675
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pulmonary tuberculosis chemotherapy topics at the XXII International Conference on Tuberculosis in Tokyo].
    Anastasatu C
    Ftiziologia; 1974; 23(2):113-21. PubMed ID: 4151757
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy in Thailand.
    Sriyabhaya N
    Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():49. PubMed ID: 4122887
    [No Abstract]   [Full Text] [Related]  

  • 13. Another step on the path to better TB therapies.
    Vernon A; Burman W; Horsburgh CR
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):1-2. PubMed ID: 11931394
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomarkers for tuberculosis disease activity, cure, and relapse.
    Phillips PP; Davies GR; Mitchison DA
    Lancet Infect Dis; 2010 Feb; 10(2):69-70; author reply 70-1. PubMed ID: 20113973
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence and predictors of default from tuberculosis treatment in Hong Kong.
    Chan-Yeung M; Noertjojo K; Leung CC; Chan SL; Tam CM
    Hong Kong Med J; 2003 Aug; 9(4):263-8. PubMed ID: 12904614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy in Australia.
    McManis AG
    Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():51. PubMed ID: 4145679
    [No Abstract]   [Full Text] [Related]  

  • 17. [Short term chemotherapy of tuberculosis. Factors affecting relapse following short term chemotherapy].
    Aber VR; Nunn AJ
    Bull Int Union Tuberc; 1978 Dec; 53(4):276-80. PubMed ID: 387141
    [No Abstract]   [Full Text] [Related]  

  • 18. A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.
    Am Rev Respir Dis; 1989 Apr; 139(4):871-6. PubMed ID: 2648911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1987 Dec; 136(6):1339-42. PubMed ID: 2891333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of newly detected cases of pulmonary tuberculosis prior to the results of determining the drug sensitivity of Mycobacterium tuberculosis].
    Rudoĭ NM; Krivenko GT
    Probl Tuberk; 1988; (11):24-8. PubMed ID: 3146752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.